BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Gene and Cell Therapy

2 posts

When you think of the future, keep in mind that the field of regenerative medicine is rapidly advancing. Cell and gene therapies are a new kind of medicine with enormous potential still to be realized. Most current, small-molecule medicines are made in a standardized way and have a limited lifespan within the body.

Cell and gene therapies are not the same as existing drugs. They entail removing cells, protein, or genetic material (DNA) from the patient (or a donor), modifying them in a personalized way for individual needs before re-injecting them into the patient.

Cell and gene therapies may provide longer-lasting effects than traditional medicines. They have the potential to treat serious illnesses such as motor neuron disease, as well as a variety of uncommon problems for which there are no effective treatments.

Gene Therapy

Gene therapy in its most broad definition is the use of genetic material to cure or treat a disease. The introduced genetic material affects how a single protein or group of proteins is manufactured by the cell.

A variety of diseases have been treated with gene therapy, including muscular dystrophy and Leber’s congenital amaurosis. It can be used to decrease levels of a disease-causing form of a protein, increase production of disease-fighting proteins, or generate new/modified proteins.

Cell Therapy

Cell therapy is the transfer of viable, live cells into a patient to assist with curing or treating an illness. The cells may come from the patient (autologous) or a donor (allogeneic). Cells used in cell therapy can be categorized according to their potential to convert into various cell types. The type of cells administered to the patient depends on the treatment needs.

Cell Therapy vs. Gene Therapy

Cell therapy is a treatment that aims to cure illnesses by regenerating or modifying specific sets of cells, as well as using cells to deliver a drug via circulation throughout the body.

The cells may be fabricated outside the body and then injected into the patient with cell therapy. Autologous cells come from the patient (end autologous), whereas allogeneic cells do not (end allogeneic).

Gene therapy seeks to cure diseases by replacing, inactivating, or introducing genes into cells inside or outside the body (in vivo) or vice versa (ex vivo).

Both cell and gene therapies are referred to as “treatments.” These treatments function by modifying genes in particular sorts of cells and transplanting them into the body. Some therapies are considered both cell and gene therapies.

BioTech CEO InterviewsThe Future of Cell & Gene Therapy Logistics with Cryoport | Interview with CEO Mark Sawicki

  • BioTech Health X
  • July 25, 2024
In an exclusive interview with BioTech Health X host Allison Goodlove, Cryoport (NASDAQ: CYRX) President & CEO Mark…
0 Shares
0
0
0
0
0
0
0
Capricor CEO to Present at American Society of Gene and Cell Therapy Annual Meeting Ahead of Q1 Earnings Update

Biotech NewsCapricor CEO to Present at American Society of Gene and Cell Therapy Annual Meeting Ahead of Q1 Earnings Update

  • BioTech Health X
  • May 12, 2021
May 13 is a busy day for biotechnology company Capricor Therapeutics (NASDAQ: CAPR). The company which focuses on…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • CeriBell (CBLL) is a Smart MedTech Play in 2025
  • CAMP4 Therapeutics (CAMP) is Game-Changer in RNA-Driven Drug Discovery
  • Upstream Bio (UPB) is Poised to Disrupt the Respiratory Disease Market
  • Septerna (SEPN) & Novo Nordisk Join Forces to Target Obesity & Diabetes
  • Zenas BioPharma (ZBIO) is a Rising Star in Autoimmune Drug Development
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • May 30, 2025
    CeriBell (CBLL) is a Smart MedTech Play in 2025
    • May 30, 2025
    CAMP4 Therapeutics (CAMP) is Game-Changer in RNA-Driven Drug Discovery
    • May 30, 2025
    Upstream Bio (UPB) is Poised to Disrupt the Respiratory Disease Market
    • May 30, 2025
    Septerna (SEPN) & Novo Nordisk Join Forces to Target Obesity & Diabetes
    • May 30, 2025
    Zenas BioPharma (ZBIO) is a Rising Star in Autoimmune Drug Development
Recent Posts
  • MBX Biosciences Is Building the Future of Hormone Therapy
    • May 30, 2025
  • Bicara Therapeutics (BCAX) is a High-Potential Biotech Stock in 2025
    • May 30, 2025
  • Crinetics Pharmaceuticals (CRNX) Could Be the Next Biotech Breakout
    • May 30, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (155)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top